Dr. Scott Gottlieb
Resident Fellow, American Enterprise Institute, Washington, D.C.
A practicing physician, Dr. Scott Gottlieb has served in various capacities at the Food and Drug Administration (FDA). He has been a Senior Adviser for Medical Technology, Director of Medical Policy Development, and most recently Deputy Commissioner for Medical and Scientific Affairs. Dr. Gottlieb has also served as a senior policy adviser at the Centers for Medicare and Medicaid Services (CMS).
Professional Experience
-Deputy Commissioner for Medical and Scientific Affairs, FDA, 2005-2007
-Medical Internist, Stamford Hospital, 2003-2007
-Resident Fellow, American Enterprise Institute, 2004-2005
-Senior Adviser to the Administrator, CMS, 2004
-Director of Medical Policy Development, FDA, 2004
-Senior Adviser for Medical Technology to the FDA Commissioner, 2003-2004
-Columnist, Forbes.com, 2007-present
-Author, Forbes-Gottlieb Medical Technology Report, 2004-2005
-Staff Writer, British Medical Journal, 1997-2005
-Author, Gilder Biotech Report, 2000-2002
-Senior Editor, Pulse, Journal of the American Medical Association, 1996-2001
-Health Care Analyst, Alex Brown & Sons (investment bank), 1994-1995
Education
M.D., Mount Sinai School of Medicine
B.A., economics, Wesleyan University